NCT02398149

Brief Summary

Upper extremity (UE) function is critical to maintaining independence. Better understanding of UE involvement in MS will provide necessary information to prioritize the design and selection of future interventions. The goal of the proposed project is to characterize UE involvement in a population of community-based persons with MS across the International Classification of Functioning, Disability \& Health (ICF) domains and constructs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
267

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

March 2, 2015

Completed
23 days until next milestone

First Posted

Study publicly available on registry

March 25, 2015

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

August 30, 2017

Status Verified

August 1, 2017

Enrollment Period

3 years

First QC Date

March 2, 2015

Last Update Submit

August 28, 2017

Conditions

Multiple Sclerosis

Outcome Measures

Primary Outcomes (1)

  • Prevalance of Impairment in the Upper Extremity

    3hours

Study Arms (1)

PwMS receiving care at the Mandell Center

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Persons with MS who receive care at the Mandell Center for Multiple Sclerosis.

You may qualify if:

  • Confirmed clinical Clinical diagnosis of MS
  • Receive MS care at the Mandell MS Center
  • Cognitively able to understand directions and complete protocol
  • Signed consent form approved by the Saint Francis Institutional Review Board
  • years of age or older

You may not qualify if:

  • Unwilling or unable to complete assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mandell Center for Multiple Sclerosis at the Mount Sinai Rehabilitation Hospital

Hartford, Connecticut, 06112, United States

Location

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Manager, Mandell MS Center

Study Record Dates

First Submitted

March 2, 2015

First Posted

March 25, 2015

Study Start

October 1, 2013

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

August 30, 2017

Record last verified: 2017-08

Locations

US(1)